Paper 45 - A PHASE II STUDY OF PALBOCICLIB COMBINED WITH THE PD-1 INHIBITOR RETIFANLIMAB IN PATIENTS WITH ADVANCED DEDIFFERENTIATED LIPOSARCOMA

Author(s)

• 

  Evan Rosenbaum, MD

  Assistant Attending
  Memorial Sloan Kettering Cancer Center
  New York, New York, United States

  Slides

Co-Author(s)

• LQ

  Li-Xuan Qin, PhD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• RG

  Rodrigo Gularte Mérida, Ph. D.

  Senior Research Scientist
  Memorial Sloan Kettering Cancer Center
  new York, New York, United States
• ES

  Evan Seffar, MS

  Computational Biologist
  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• MD

  Mark Dickson, MD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• SM

  Sujana Movva, MD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• CK

  Ciara Kelly, MD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• 

  Viswatej Avutu, MD (he/him/his)

  Assistant Attending
  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• JC

  Jason Chan, MD, PhD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• PC

  Ping Chi, MD, PhD

  Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine
  New York, New York, United States
• 

  Lauren Banks, MD, PhD (she/her/hers)

  Assistant Attending
  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• MK

  Mary Lou Keohan, MD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• MG

  Mrinal Gounder, MD

  Memorial Sloan Kettering Cancer Center; Weill Cornell Medical College
  New York, New York, United States
• 

  Robert G. Maki, MD, PhD (he/him/his)

  Member & Professor of Medicine
  Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College
  New York, New York, United States
• DR

  Damon Reed, MD

  Memorial Sloan Kettering
  New York, New York, United States
• JC

  Jae Cho, n/a

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• MB

  Matthew Biniakewitz, RN

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• RD

  Rhoena Desir, n/a

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• JE

  Joseph Erinjeri, MD, PhD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• RL

  Robert Lefkowitz, MD

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• AK

  Andrew Koff, Ph. D.

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• SS

  Samuel Singer, MD, FACS

  Memorial Sloan Kettering Cancer Center
  New York, New York, United States
• WT

  William D. Tap, MD

  Department of Medicine, Memorial Sloan Kettering Cancer Center Department of Medicine, Weill Cornell Medical College
  New York, New York, United States
• SD

  Sandra P. D'Angelo, MD

  Associate Attending
  Memorial Sloan Kettering Cancer Center
  New York, New York, United States